Cargando…

Long term disease free survival with multimodal therapy in small cell bladder cancer

BACKGROUND: Small cell bladder cancer (SCBC) is an aggressive subtype accounting for less than 1 % of all bladder malignancies associated with rapid progression, early metastases formation and high mortality rates. CASE PRESENTATION: We present an unusual long term disease free survival of a 60 year...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heidegger, Isabel, Tulchiner, Gennadi, Schäfer, Georg, Horninger, Wolfgang, Pichler, Renate
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064780/ https://www.ncbi.nlm.nih.gov/pubmed/27737712 http://dx.doi.org/10.1186/s40001-016-0234-9

Ejemplares similares

Urinary UBC Rapid and NMP22 Test for Bladder Cancer Surveillance in Comparison to Urinary Cytology: Results from a Prospective Single-Center Study
por: Pichler, Renate, et al.
Publicado: (2017)

The “COVID-19 Pandemic Gap” and Its Influence on Oncologic Outcomes of Bladder Cancer
por: Tulchiner, Gennadi, et al.
Publicado: (2021)

Adenomatoid tumor of the testis mimicking malignant testicular cancer on multiparametric ultrasound
por: Pichler, Renate, et al.
Publicado: (2018)

Organ-Sparing Surgery in Testicular Tumor: Is This the Right Approach for Lesions ≤ 20 mm?
por: Staudacher, Nina, et al.
Publicado: (2020)

A presumed extragonadal germ cell tumor that turned out to be a gastric cancer—a case report
por: Kafka, Mona, et al.
Publicado: (2021)

Sex-specific hormone changes during immunotherapy and its influence on survival in metastatic renal cell carcinoma
por: Tulchiner, Gennadi, et al.
Publicado: (2021)

Immune-related lichenoid mucocutaneous erosions during anti-PD-1 immunotherapy in metastatic renal cell carcinoma - A case report
por: Lindner, Andrea Katharina, et al.
Publicado: (2018)

Vinorelbine in bladder-preserving multimodality treatment for muscle-invasive bladder cancer—a valid option for cisplatin-unfit patients?
por: Arnold, C. R., et al.
Publicado: (2021)

CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma
por: Tulchiner, Gennadi, et al.
Publicado: (2021)

Gender-related Outcome in Bladder Cancer Patients undergoing Radical Cystectomy
por: Pichler, Renate, et al.
Publicado: (2017)

Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study
por: Pichler, Renate, et al.
Publicado: (2021)

ASCO 2018: highlights of urothelial cancer and prostate cancer
por: Pichler, Renate, et al.
Publicado: (2018)

Do we need repeated CT imaging in uncomplicated blunt renal injuries? Experiences of a high-volume urological trauma centre
por: Lindner, Andrea Katharina, et al.
Publicado: (2022)

Lynch Syndrome: Its Impact on Urothelial Carcinoma
por: Lindner, Andrea Katharina, et al.
Publicado: (2021)

Radium-223 for metastatic castration-resistant prostate cancer: results and remaining open issues after the ALSYMPCA trial
por: Heidegger, Isabel, et al.
Publicado: (2018)

Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature
por: Pircher, Andreas, et al.
Publicado: (2019)

Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program
por: Heidegger, Isabel, et al.
Publicado: (2015)

Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma
por: Lindner, Andrea Katharina, et al.
Publicado: (2022)

Antidiabetic drugs influence molecular mechanisms in prostate cancer
por: Pircher, Andreas, et al.
Publicado: (2018)

Organ-sparing surgery of penile cancer: higher rate of local recurrence yet no impact on overall survival
por: Lindner, Andrea Katharina, et al.
Publicado: (2019)

Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria
por: Tulchiner, Gennadi, et al.
Publicado: (2021)

High Risk of Under-Grading and -Staging in Prostate Cancer Patients Eligible for Active Surveillance
por: Heidegger, Isabel, et al.
Publicado: (2015)

HUS1 as a Potential Therapeutic Target in Urothelial Cancer
por: Lindner, Andrea Katharina, et al.
Publicado: (2022)

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer()
por: Heidegger, Isabel, et al.
Publicado: (2013)

Novel concepts of antiangiogenic therapies in metastatic renal cell cancer
por: Pichler, Renate, et al.
Publicado: (2017)

High economic burden of immunotherapy underlines the need of predictive biomarkers for the individual therapy algorithm in metastatic bladder cancer
por: Pichler, Renate, et al.
Publicado: (2018)

Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality
por: Pircher, Andreas, et al.
Publicado: (2017)

Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer
por: Pichler, Renate, et al.
Publicado: (2016)

Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy
por: Heidegger, Isabel, et al.
Publicado: (2019)

Five-Year, Disease-Free Survival after Repeat Palliative Multimodality Therapy in a Patient with Recurrent Metastastic Bladder Cancer
por: Fetscher, Sebastian, et al.
Publicado: (2007)

Long-Term Treatment-Free Survival After Multimodal Therapy in a Patient with Stage IV Lung Adenocarcinoma
por: Takaoka, Hatsuyo, et al.
Publicado: (2022)

PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy
por: Pichler, Renate, et al.
Publicado: (2017)

Cholesterol pathway the Achilles heel in prostate cancer metastasis
por: Heidegger, Isabel, et al.
Publicado: (2018)

Small-cell neuroendocrine tumor of the bladder: Unexpected long-term survival with carboplatin-etoposide therapy in a patient with metastatic stage disease
por: Rico, Eduardo J. García, et al.
Publicado: (2023)

Aggressive Multimodal Approach for Anaplastic Thyroid Cancer and Long-Term Survival
por: Hussain, Nasir, et al.
Publicado: (2013)

Long-term cancer survival prediction using multimodal deep learning
por: Vale-Silva, Luís A., et al.
Publicado: (2021)

Progression-Free Survival: An Important Prognostic Marker for Long-Term Survival of Small Cell Lung Cancer
por: Park, Myoung-Rin, et al.
Publicado: (2014)

Angiosarcoma of the Seminal Vesicle: A Case Report of Long-Term Survival Following Multimodality Therapy
por: Chang, Kenneth, et al.
Publicado: (2014)

Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report
por: Sota, Yuki, et al.
Publicado: (2021)

Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment
por: Lee, Haejun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7d2al2lobvqka4jh008e487c3h